The Centers for Medicare & Medicaid Services (CMS) recently concluded the first round of negotiation for the new Medicare Drug Price Negotiation Program, which was established by the Inflation Reduction Act. These FAQs address several questions related to Medicare’s drug price negotiation program and CMS’s implementation of the new program, with a focus on the details that apply for 2026, the first year that negotiated prices will be available under this new program.
FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
